After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
A defrocked analyst brushes off the serious problems weighing on Northwest Bio. Instead, he jacks the tired 'blame the shorts' excuse to another level.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
These under-$10 stocks are making big moves higher. Here's how to trade them from here.
TheStreet's Senior Columnist Adam Feuerstein answers reader questions about biotech stocks.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.